Aricept and Akineton drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Aricept (donepezil hydrochloride) and Akineton (biperiden hydrochloride). Common drug interactions include dystonia among females and neuroleptic malignant syndrome among males.
The phase IV clinical study analyzes what interactions people have when they take Aricept and Akineton. It is created by eHealthMe based on reports of 32 people who take the same drugs from the FDA, and is updated regularly.
What is Aricept?
Aricept has active ingredients of donepezil hydrochloride. It is often used in alzheimer's disease. eHealthMe is studying from 24,756 Aricept users. Check the latest studies of Aricept.
What is Akineton?
Akineton has active ingredients of biperiden hydrochloride. It is often used in parkinson's disease. eHealthMe is studying from 6,140 Akineton users. Check the latest studies of Akineton.
32 people who take Aricept and Akineton together, and have interactions are studied.

What are the common drug interactions of Aricept and Akineton, by gender? *:
female:
- Dystonia (abnormal muscle tone)
- Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
- Cardiac failure
- Confusional state
- Delirium (wild excitement)
- Disorientation (disability in which the senses of time, direction, and recognition of people and places)
- Dyspnoea (difficult or laboured respiration)
- Gastric ulcer haemorrhage (bleeding ulcer of stomach)
- General physical health deterioration (weak health status)
- Nausea (feeling of having an urge to vomit)
male:
- Neuroleptic malignant syndrome (a life-threatening neurological disorder most often caused by an adverse reaction to neuroleptic or antipsychotic agents)
- Pneumonia
- Hyperglycaemia (high blood sugar)
- Loss of consciousness
- Miosis (constriction of the pupil of the eye, resulting from a normal response to an increase in light)
- Pneumonitis aspiration (acute lung injury after the inhalation of regurgitated gastric contents)
- Pyrexia (fever)
- Respiratory depression (respiration has a rate below 12 breaths)
- Respiratory failure (inadequate gas exchange by the respiratory system)
- White blood cells urine positive
What are the common drug interactions of Aricept and Akineton, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
n/a
60+:
- Neuroleptic malignant syndrome (a life-threatening neurological disorder most often caused by an adverse reaction to neuroleptic or antipsychotic agents)
- Pneumonia
- Miosis (constriction of the pupil of the eye, resulting from a normal response to an increase in light)
- Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
- Cardiac failure
- Coma (state of unconsciousness lasting more than six hours)
- Confusional state
- Disorientation (disability in which the senses of time, direction, and recognition of people and places)
- Dyspnoea (difficult or laboured respiration)
- Gastric ulcer haemorrhage (bleeding ulcer of stomach)
What are the existing conditions these people have? *
- Dementia (madness): 13 people, 40.62%
- High Blood Pressure: 10 people, 31.25%
- Dementia Alzheimer's Type (loss of mental ability with alzheimer's symptom): 6 people, 18.75%
- Constipation: 4 people, 12.50%
- Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 3 people, 9.38%
- Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 3 people, 9.38%
- Depression: 3 people, 9.38%
- Insomnia (sleeplessness): 2 people, 6.25%
- Hyperuricaemia (level of uric acid in the blood that is abnormally high): 2 people, 6.25%
- Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood): 2 people, 6.25%
* Approximation only. Some reports may have incomplete information.
Do you take Aricept and Akineton?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Aricept and Akineton:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Aricept:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Akineton:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Aricept and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Akineton and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on donepezil hydrochloride and biperiden hydrochloride (the active ingredients of Aricept and Akineton, respectively), and Aricept and Akineton (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Trelegy Ellipta cause Psoriasis? - 19 seconds ago
- Energy Increased and drugs of ingredients of secukinumab - 19 seconds ago
- Could Megace cause Carotid Artery Stenosis? - 47 seconds ago
- Could Asa cause Aseptic Necrosis? - 48 seconds ago
- Could Breo Ellipta cause Bronchitis Chronic? - 53 seconds ago
- Could Integrilin cause International Normalised Ratio Increased? - 55 seconds ago
- Could Ambisome cause Hydrocephalus? - 55 seconds ago
- Harvoni and Copegus drug interactions for men aged 60+ - 55 seconds ago
- Colace and Pharyngitis for Women aged 30-39 - a minute ago
- Veletri and Viral Infection for Women aged 20-29 - a minute ago